LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support.
Livanova stock last closed at $45.76, down 1.87% from the previous day, and has decreased 12.49% in one year. It has overperformed other stocks in the Medical Devices industry by 0.04 percentage points. Livanova stock is currently +40.89% from its 52-week low of $32.48, and -20.21% from its 52-week high of $57.35.
At the moment, there are 54.53M shares of LIVN outstanding. The market capitalization of LIVN is $2.50B. In the last 24 hours, 417,000 LIVN shares were traded.
How to Buy Livanova Stock
Wondering how to invest in Livanova stock? Here's how.
Choose where to buy Livanova stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Livanova stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Choose your payment method and add your information.
Evaluate Livanova stock: The Livanova ticker symbol is LIVN. Is Livanova stock a good investment? Should you buy shares of LIVN? How do LIVN's underlying business fundamentals look? Do top analysts think Livanova is a good buy? Why has LIVN's stock price moved recently? (Hint: Our stock market research tools can help you understand if LIVN is a good stock to buy).
Make your LIVN trade: Decide if you will purchase LIVN shares at the current market price or use a limit order to purchase LIVN stock at a particular price.
Get key alerts regarding your LIVN investment: Create a watchlist to monitor your position in Livanova shares.
Step 1: Choose where to buy Livanova stock
You will need a brokerage account in order to access the NASDAQ market and buy LIVN stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you can invest in LIVN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Livanova stock
After you have identified the best place to buy Livanova stock, it's crucial to analyze their stock before you buy, so you truly wrap your head around the risk and upside.
Livanova Numbers
LIVN Price
$45.76
1w %
-0.41%
1y %
-12.49%
5y %
-3.01%
P/E
-11.24x
P/B
2.41x
P/S
1.95x
PEG
N/A
Revenue
$1.28B
Earnings
-$222.15M
Fore. Rev. Growth
4.67%
Fore. Earn. Growth
N/A
Market Cap
$2.50B
Next Earnings
Jul 29, 2025
Next Dividend
N/A
Livanova Overview
WallStreetZen was built to help average investors perform more in-depth fundamental analysis.
There are more short-term assets than short-term liabilities on the LIVN balance sheet.
LIVN's operating cash flow of $197.02M allows it to safely service it's debt of $669.12M.
There are more short-term assets than long-term liabilities on the LIVN balance sheet.
Signs that LIVN is not financially healthy:
Total LIVN debt is higher than 5 years ago, relative to shareholder equity.
LIVN earnings of -$130.69M is not sufficient to cover its interest payments.
LIVN profit margin has gone down from -2.7% to -17.4% in the past year.
LIVN has a relatively high debt to equity ratio of 1.47.
Do analysts think it's a good time to buy LIVN stock
Out of 7 Equities analysts who give recommendations on LIVN, the consensus analyst rating on LIVN is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest LIVN Analyst Forecasts
Anthony Petrone, a top 11% analyst from Mizuho maintains LIVN with a buy rating and lowers their LIVN price target from $70.00 to $60.00, on Feb 26, 2025.
Rick Wise, a top 9% analyst from Stifel Nicolaus maintains LIVN with a strong buy rating and lowers their LIVN price target from $72.00 to $60.00, on Feb 26, 2025.
Stifel Nicolaus's Rick Wise lowered their price target on Livanova (NASDAQ: LIVN) by 16.7% from $72 to $60 on 2025/02/26. The analyst maintained their Strong Buy rating on the stock.
LivaNova PLC reported its Q4 and FY 2024 earnings.
Looking ahead after cutting their price target, Wise said that "three potential story-shifting catalysts are on the horizon in 2025," including the SNIA litigation final supreme court ruling, OSPREY obstructive-sleep-apnea data, and the RECOVER depression trial final CMS data submission.
Earnings Report
LivaNova PLC reported:
For Q4 2024:
EPS of $0.81, which beat the Zacks Consensus Estimate of $0.80 but missed Q4 2023's $0.87.
Revenue of $321.8M, which missed the Zacks Consensus Estimate by 0.48% but beat Q4 2023's $310.1M.
For FY 2024:
EPS of $3.38, up from FY 2023's $2.80.
Revenue of $1.25B, up from FY 2023's $1.15B.
For FY 2025, management guided:
EPS of $3.65 to $3.75.
5% to 6% Y/Y revenue growth.
CEO Vladimir Makatsaria commented: "In 2024, LivaNova delivered strong revenue growth, expanded operating margin, and significantly improved cash generation.
"We are pleased with these results and the clinical milestones achieved in both the obstructive sleep apnea and difficult-to-treat depression programs.
"We look forward to building on this momentum in 2025 with a continued focus on talent, innovation, growth, and operational excellence."
Last year, LIVN revenue was $1.28B. During the last 5 year, LIVN's revenue has grown by 3.46% per year. This was slower than the Medical Devices industry average of 9.62%.
No, Livanova doesn't provide an income stream by paying out dividends.
What do other investors have to say about LIVN?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your LIVN trade
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually fine.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you need more help buying stocks on eToro, watch the how to video below:
As of Jun 13, 2025, it costs $45.76 to buy one share of Livanova stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.219 shares of LIVN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.